Knowledge, Attitude and Perception of Pregnant Women Regarding Medications

Assessment Of Knowledge, Attitude and Perception of Pregnant Women Regarding Medications Use

The goal of this observational study is to learn about the pregnant women's knowledge, attitude, and perception regarding the use of medications in pregnancy. The main question it aims to answer is:

What is the present knowledge, attitude, and perception of pregnant women regarding medication use?

Participants (pregnant women) already attending the antenatal clinic for routine follow-up will answer survey questions about their knowledge, attitude, and beliefs about medication use and restriction during pregnancy, as well as the source of their information.

Study Overview

• Status: Active, not recruiting
• Conditions: Medications in Pregnancy
• Intervention / Treatment: Other: Questionnaire

Detailed Description

This is a descriptive cross-sectional study (survey) that will be held at Ain shams University Maternity Hospital.

The protocol approval will be sought from the ethical committee of department of Obstetrics and Gynecology, Ain Shams University.

• Data collection (the questionnaire): The study will use anonymous questionnaire; based upon previous similar studies.

The questionnaire comprises closed-ended questions categorized into four sections, along with fifth section consisting of statements pertaining to respondents' beliefs:

A. Section A (10 items) will contain information about the participant's socio-demographic and health related characteristics.

B. Section B (7 items) will assess their knowledge about medication use and restriction, during pregnancy.

C. Section C (4 items) will assess their attitude about medication. D. Section D (4 items) will assess the source of their information. E. Section E (9 statements) will assess their beliefs about medications use during pregnancy.

This questionnaire will be presented in its Arabic version and pre-tested on 15 pregnant women to evaluate the construct and content validity, as well as to determine if any modifications to wording are necessary. These participants will not be included in the final analysis.

The questionnaire will be distributed to pregnant women who attend the hospital for their routine antenatal check-up visits. In instances where women are unable to read or write, the principal investigator and attending house officer in the unit will provide assistance in reading and explaining the questions to facilitate the completion of the questionnaire.

• Data will be collected and recorded.
• Statistical analysis will be done accordingly.

• Study Type: Observational
• Enrollment (Estimated): 150

Contacts and Locations

Study Locations

• Egypt
  • Cairo, Egypt
    • Ain Shams University Maternity Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Pregnant women who attend the Ain shams University Maternity Hospital for their routine antenatal check-up visits

Description

Inclusion Criteria:

• Pregnant women attending the Ain shams University Maternity Hospital

Exclusion Criteria:

• Pregnant ladies refusing to participate in study.
• Pregnant ladies needing immediate transport to emergency department.
• Pregnant ladies needing immediate intervention.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Pregnant women; Pregnant women attending the Ain shams University Maternity Hospital

Other: Questionnaire; This is an anonymous questionnaire; based upon previous similar studies. The questionnaire comprises closed-ended questions categorized into four sections, along with fifth section consisting of statements pertaining to respondents' beliefs: A. Section A (10 items) will contain information about the participant's socio-demographic and health related characteristics. B. Section B (7 items) will assess their knowledge about medication use and restriction, during pregnancy. C. Section C (4 items) will assess their attitude about medication. D. Section D (4 items) will assess the source of their information. E. Section E (9 statements) will assess their beliefs about medications use during pregnancy. This questionnaire will be presented in its Arabic version.; Other Names: survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Knowledge of pregnant women regarding medication use and restriction in pregnancy.	Degree of knowledge (information) that the pregnant women have about medication use and restriction during pregnancy, as well as the source of their information, as assessed by answering the questions in sections B and D in the questionnaire.	Once at recruitment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Attitude of pregnant women regarding medication use	The attitudes of the pregnant women towards medication use during pregnancy, as assessed by answering the questions in section C in the questionnaire.	Once at recruitment
Perception and beliefs of pregnant women regarding medication use and restriction	The beliefs of the pregnant women regarding medication use during pregnancy, as assessed by answering the questions in section E in the questionnaire.	Once at recruitment

Collaborators and Investigators

• Sponsor: Rania Hassan Mostafa
• Investigators: Study Chair: Ahmed Khairy, MD, Faculty of Medicine, Ain Shams University.; Study Director: Ebtihal M Eltaieb, MD, Faculty of Medicine, Ain Shams University.

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2025
• Primary Completion (Actual): October 12, 2025
• Study Completion (Estimated): January 1, 2026

Study Registration Dates

• First Submitted: April 7, 2025
• First Submitted That Met QC Criteria: April 7, 2025
• First Posted (Actual): April 13, 2025

Study Record Updates

• Last Update Posted (Actual): December 8, 2025
• Last Update Submitted That Met QC Criteria: December 1, 2025
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Keywords: medication; pregnancy; perception; knowledge; attitude; teratogenic
• Additional Relevant MeSH Terms: Behavior; Health Care Quality, Access, and Evaluation; Investigative Techniques; Epidemiologic Methods; Data Collection; Health Care Evaluation Mechanisms; Quality of Health Care; Public Health; Environment and Public Health; Surveys and Questionnaires
• Other Study ID Numbers: FMASU MS 185/2025

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: The study protocol, the questionnaire used, and the analytic code will be made available on OSF platform.
• IPD Sharing Time Frame: The study protocol and the questionnaire used will be available starting (May 2025) till (May 2030) The analytic code will be available after publishing the results (expected by May 2026) for 5 years
• IPD Sharing Access Criteria: The study protocol, the questionnaire used, and the analytic code will be made PUBLICLY available on OSF platform.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; ANALYTIC_CODE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No